Literature DB >> 24165314

Features of occult invasion in biopsy-proven DCIS at breast MRI.

Dorota Jakubowski Wisner1, E Shelley Hwang, C Belinda Chang, Hilda H Tso, Bonnie N Joe, Juan N Lessing, Ying Lu, Nola M Hylton.   

Abstract

The purpose of this study is to determine if MRI BI-RADS criteria or radiologist perception correlate with presence of invasive cancer after initial core biopsy of ductal carcinoma in situ (DCIS). Retrospective search spanning 2000-2007 identified all core-biopsy diagnoses of pure DCIS that coincided with preoperative MRI. Two radiologists fellowship-trained in breast imaging categorized lesions according to ACR MRI BI-RADS lexicon and estimated likelihood of occult invasion. Semiquantitative signal enhancement ratio (SER) kinetic analysis was also performed. Results were compared with histopathology. 51 consecutive patients with primary core biopsy-proven DCIS and concurrent MRI were identified. Of these, 13 patients (25%) had invasion at excision. Invasion correlated significantly with presence of a mass for both readers (p = 0.012 and 0.001), rapid initial enhancement for Reader 1 (p = 0.001), and washout kinetics for Reader 2 (p = 0.012). Significant correlation between washout and invasion was confirmed by SER (p = 0.006) when threshold percent enhancement was sufficiently high (130%), corresponding to rapidly enhancing portions of the lesion. Radiologist perception of occult invasion was strongly correlated with true presence of invasion. These results provide evidence that certain BI-RADS MRI criteria, as well as radiologist perception, correlate with occult invasion after an initial core biopsy of DCIS.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast; carcinoma; ductal carcinoma in situ; invasive ductal carcinoma; invasive lobular carcinoma; kinetics; magnetic resonance imaging; signal enhancement ratio

Mesh:

Year:  2013        PMID: 24165314      PMCID: PMC4036640          DOI: 10.1111/tbj.12201

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  30 in total

1.  Imaging-histologic discordance at percutaneous breast biopsy.

Authors:  L Liberman; M Drotman; E A Morris; L R LaTrenta; A F Abramson; M F Zakowski; D D Dershaw
Journal:  Cancer       Date:  2000-12-15       Impact factor: 6.860

2.  Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.

Authors:  D M Ikeda; N M Hylton; K Kinkel; M G Hochman; C K Kuhl; W A Kaiser; J C Weinreb; S F Smazal; H Degani; P Viehweg; J Barclay; M D Schnall
Journal:  J Magn Reson Imaging       Date:  2001-06       Impact factor: 4.813

Review 3.  Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.

Authors:  Mahmud Mossa-Basha; Gina M Fundaro; Biren A Shah; Sharif Ali; Milan V Pantelic
Journal:  Radiographics       Date:  2010-10       Impact factor: 5.333

4.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.

Authors:  R J Jackman; F Burbank; S H Parker; W P Evans; M C Lechner; T R Richardson; A A Smid; H B Borofsky; C H Lee; H M Goldstein; K J Schilling; A B Wray; R F Brem; T H Helbich; D E Lehrer; S J Adler
Journal:  Radiology       Date:  2001-02       Impact factor: 11.105

5.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Authors:  Nola M Hylton; Jeffrey D Blume; Wanda K Bernreuter; Etta D Pisano; Mark A Rosen; Elizabeth A Morris; Paul T Weatherall; Constance D Lehman; Gillian M Newstead; Sandra Polin; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

6.  The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.

Authors:  Mariko Goto; Sachiko Yuen; Kentaro Akazawa; Kaori Nishida; Eiichi Konishi; Mariko Kajihara; Nobuhiko Shinkura; Kei Yamada
Journal:  Eur Radiol       Date:  2011-12-30       Impact factor: 5.315

7.  MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.

Authors:  Yu-Ting Huang; Yun-Chung Cheung; Yung-Feng Lo; Shir-Hwa Ueng; Wen-Ling Kuo; Shin-Cheh Chen
Journal:  Acta Radiol       Date:  2011-10-03       Impact factor: 1.990

8.  Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.

Authors:  P M Hoff; V Valero; A U Buzdar; S E Singletary; R L Theriault; D Booser; L Asmar; D Frye; M D McNeese; G N Hortobagyi
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

9.  Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.

Authors:  J Mathew; A Agrawal; K S Asgeirsson; S A Buhari; L R Jackson; K L Cheung; J F R Robertson
Journal:  Breast Cancer Res Treat       Date:  2008-03-02       Impact factor: 4.872

10.  Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.

Authors:  Yunn-Yi Chen; Sandy DeVries; Joseph Anderson; Juan Lessing; Rebecca Swain; Koei Chin; Veronica Shim; Laura J Esserman; Frederic M Waldman; E Shelley Hwang
Journal:  BMC Cancer       Date:  2009-08-18       Impact factor: 4.430

View more
  6 in total

1.  Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.

Authors:  Marc D Ryser; Mathias Worni; Elizabeth L Turner; Jeffrey R Marks; Rick Durrett; E Shelley Hwang
Journal:  J Natl Cancer Inst       Date:  2015-12-17       Impact factor: 13.506

2.  Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).

Authors:  E Shelley Hwang; Terry Hyslop; Laura H Hendrix; Stephanie Duong; Isabelle Bedrosian; Elissa Price; Abigail Caudle; Tina Hieken; Joseph Guenther; Clifford A Hudis; Eric Winer; Alan P Lyss; Diana Dickson-Witmer; Richard Hoefer; David W Ollila; Timothy Hardman; Jeffrey Marks; Yunn-Yi Chen; Gregor Krings; Laura Esserman; Nola Hylton
Journal:  J Clin Oncol       Date:  2020-03-03       Impact factor: 44.544

Review 3.  Machine learning in breast MRI.

Authors:  Beatriu Reig; Laura Heacock; Krzysztof J Geras; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2019-07-05       Impact factor: 4.813

4.  Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?

Authors:  Michael R Harowicz; Ashirbani Saha; Lars J Grimm; P Kelly Marcom; Jeffrey R Marks; E Shelley Hwang; Maciej A Mazurowski
Journal:  J Magn Reson Imaging       Date:  2017-02-09       Impact factor: 4.813

5.  Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy.

Authors:  Hemei Zhou; Jing Yu; Xiaodong Wang; Kunwei Shen; Jiandong Ye; Xiaosong Chen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

6.  Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.

Authors:  Kwan Ho Lee; Jeong Woo Han; Eun Young Kim; Ji Sup Yun; Yong Lai Park; Chan Heun Park
Journal:  BMC Cancer       Date:  2019-12-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.